Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001354488-12-003912
Filing Date
2012-08-08
Accepted
2012-08-08 08:30:20
Documents
13
Period of Report
2012-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT sbfm_10q.htm 10-Q 830515
2 CERTIFICATION sbfm_ex311.htm EX-31.1 15351
3 CERTIFICATION sbfm_ex312.htm EX-31.2 15104
4 CERTIFICATION sbfm_ex32.htm EX-32 8037
11 img001.jpg GRAPHIC 34438
12 img002.jpg GRAPHIC 35389
13 img003.jpg GRAPHIC 28071
  Complete submission text file 0001354488-12-003912.txt   1642577

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT sbfm-20120630.xml EX-101.INS 37743
6 XBRL TAXONOMY EXTENSION SCHEMA sbfm-20120630.xsd EX-101.SCH 8410
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE sbfm-20120630_cal.xml EX-101.CAL 19026
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE sbfm-20120630_def.xml EX-101.DEF 5341
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE sbfm-20120630_lab.xml EX-101.LAB 71856
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sbfm-20120630_pre.xml EX-101.PRE 50594
Mailing Address 2015 PEEL STREET 5TH FLOOR MONTREAL A8 H3A 1T8
Business Address 2015 PEEL STREET 5TH FLOOR MONTREAL A8 H3A 1T8 514-764-9698
Sunshine Biopharma, Inc (Filer) CIK: 0001402328 (see all company filings)

EIN.: 205566275 | State of Incorp.: CO | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-52898 | Film No.: 121015138
SIC: 8742 Services-Management Consulting Services